Categories: NewsPatient Care

Gulf Medical Technologies and Mayo Clinic Collaborate to Propel Klens Forward

The Collaboration Aims to Address The Unmet Clinical Challenge Of Compromised Vision In Surgery

NEW YORK, NY / ACCESSWIRE / August 27, 2024 / Kuwait-headquartered Gulf Medical Technologies (GMT) and Mayo Clinic, the world’s largest and top-ranked nonprofit medical institution, have entered into a know-how agreement. This collaboration aims to further advance Klens, a pioneering technology aimed at enhancing visual clarity during minimally invasive surgeries (MIS), including robotic and laparoscopic procedures. This endeavor will leverage the clinical, technological, business, and research expertise of both institutions, integrating strategic planning, system development, regulatory affairs, and commercialization efforts to attempt to address the persistent unmet clinical challenge of compromised vision in surgery.

GMT and Mayo Clinic teams
Dr. Michael L. Kendrick, Chief of Surgery, Mayo Clinic, Dr. Ahmad Nabeel, founder and CEO, GMT, and Nir G., Technology Development Manager, Mayo Clinic Ventures.

Surgeons can face significant and cumbersome challenges due to compromised vision caused by the frequent accumulation of debris, fog, and fluids on the lens of surgical cameras. These obstructions can cause disruptions to the surgical flow, with the potential to compromise the surgeon’s performance and, ultimately, patient safety. Despite various attempts to address this issue, the problem has persisted, underscoring its complexity. Klens, an innovative solution developed by GMT, aims to restore visual clarity in real time, allowing surgeons to operate with an unobstructed view throughout procedures. This has the potential to not only enhance surgical precision but could also contribute to better patient outcomes by shortening surgery duration and enabling surgeons to perform seamlessly, free from the disruptions or compromises caused by impaired visual clarity.

“The collaboration between GMT and Mayo Clinic represents another step forward in our mission to redefine surgical safety and precision. By combining our cutting-edge technology with Mayo Clinic’s expertise, we aim to tackle one of the most enduring challenges in minimally invasive surgery,” said Dr. Ahmad Nabeel, Founder and CEO of Gulf Medical Technologies.

Building on the strong foundation GMT has established with Klens, this will seek to propel the technology even further through joint efforts. The two entities will also work closely together to develop novel computer vision systems. These systems will aim to integrate artificial intelligence (AI) to further augment Klens’ capabilities, with the goal of providing a comprehensive solution that enhances both the surgical process and patient safety. Michael Kendrick, M.D., chair of the Department of Surgery at Mayo Clinic, will play a key role in this collaboration, bringing his clinical, innovative, and technological expertise to the table.

Mayo Clinic has a financial interest in the technology referenced in this announcement. The revenue Mayo Clinic receives is used to support its not-for-profit mission in patient care, education, and research.

Contact Information
Jennifer Wright
PR Manager
info@gulfmedtech.com

Related Images

GMT and Mayo Clinic teams
Dr. Michael L. Kendrick, Chief of Surgery, Mayo Clinic, Dr. Ahmad Nabeel, founder and CEO, GMT, and Nir G., Technology Development Manager, Mayo Clinic Ventures.
Minimally Invasive Surgery

SOURCE: Gulf Medical Technologies

View the original press release on newswire.com.

Staff

Recent Posts

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

10 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

13 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

13 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

13 hours ago